☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
transplant ineligible patients
Janssen's Darzalex (daratumumab) Combination Regimen Receives EC's Approval for Transplant Ineligible Patients with Newly Diagnose...
November 20, 2019
Janssen's Darzalex (daratumumab) Combination Regimen Receives Health Canada Approval for Transplant Ineligible Patients with Multi...
October 31, 2019
Janssen's Darzalex (daratumumab) Receives MHLW's Approval for Transplant Ineligible Patients with Multiple Myeloma in Japan
August 22, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
